Annual report pursuant to Section 13 and 15(d)

Equity Method Ivestment

v3.22.0.1
Equity Method Ivestment
12 Months Ended
Dec. 31, 2021
Equity Method Investments and Joint Ventures [Abstract]  
Equity Method Investment

9. EQUITY METHOD INVESTMENT

 

The Company’s equity method investment in related parties consists of its investment in RIH. On July 1, 2019, the Company invested $23.5 million in cash in exchange for a 47% non-controlling interest in RIH. This investment was recognized at cost on the date of the transaction. On March 5, 2020, the Company invested $23.5 million to satisfy the Company’s remaining capital commitment. Refer to Note 21, Related Parties.

 

The Company’s maximum exposure to loss on the equity method investment is the total invested capital of $47.0 million. The Company may be exposed to losses arising from the equity method investment as a result of underwriting losses recognized at Geneva Re, Ltd ("Geneva Re") or losses on Geneva Re’s investment portfolio.

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Beginning of period

 

$

47,216

 

 

$

22,522

 

Invested capital

 

 

-

 

 

 

23,500

 

Income (loss) from equity method investment in related party

 

 

(759

)

 

 

440

 

Change in share of equity method investment in related party other comprehensive income (loss)

 

 

(1,040

)

 

 

754

 

End of period

 

$

45,417

 

 

$

47,216